Send me a link:

*Text messaging rates may apply.

 Dow Down0.30% Nasdaq Up0.08%

Keryx Biopharmaceuticals Inc. (KERX)

-NasdaqCM
14.32 Up 0.11(0.77%) 9:46AM EDT - Nasdaq Real Time Price
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
Total Revenue 7,000   -   5,000  
Cost of Revenue -   -   -  
Gross Profit 7,000   -   5,000  
Operating Expenses
Research Development32,387  19,369  26,209  
Selling General and Administrative21,696  7,710  7,540  
Non Recurring -   -   -  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss (47,083) (27,079) (28,749)
Income from Continuing Operations
Total Other Income/Expenses Net351  4,358  380  
Earnings Before Interest And Taxes(46,732)(25,360)(28,369)
Interest Expense -   -   -  
Income Before Tax(46,732)(25,360)(28,369)
Income Tax Expense -   -   -  
Minority Interest -   -   -  
Net Income From Continuing Ops(46,732)(25,360)(28,369)
Non-recurring Events
Discontinued Operations -   -  246  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (46,732) (22,721) (28,123)
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares (46,732) (22,721) (28,123)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.